Free Access
Volume 20, Number 3-4, Août 2018
Page(s) 47 - 48
Section Éditorial / Editorial
Published online 24 August 2018
  • Avilés P, Domínguez JM, Guillén MJ, et al (2018) MI130004, a novel antibody-drug conjugate combining trastuzumab with a molecule of marine origin, shows outstanding in vivo activity against HER2-expressing tumors. Mol Cancer Ther 17:786–94 [CrossRef] [PubMed] [Google Scholar]
  • Wozniak A, Wang Y, Wellens J, et al (2018) Plocabulin, a tubulin inhibitor, presents antitumor activity in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST) [Abstract 3840, Session PO.ET06.11 - Novel and Canonical Targets], AACR 2018 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.